Department of Pediatrics, Tohoku University School of Medicine, Sendai, Japan.
Department of Pediatrics, Tohoku University School of Medicine, Sendai, Japan; Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
Pediatr Neurol. 2023 Sep;146:16-20. doi: 10.1016/j.pediatrneurol.2023.06.002. Epub 2023 Jun 12.
Myosin-binding protein C1 (MYBPC1) encodes myosin-binding protein C, slow type (sMyBP-C), an accessory protein that regulates actomyosin cross-linking, stabilizes thick filaments, and modulates contractility in muscle sarcomeres and has recently been linked to myopathy with tremor. The clinical features of MYBPC1 mutations manifesting in early childhood bear some similarities to those of spinal muscular atrophy (SMA), such as hypotonia, involuntary movement of the tongue and limbs, and delayed motor development. The development of novel therapies for SMA has necessitated the importance of differentiating SMA from other diseases in the early infancy period. We report the characteristic tongue movements of MYBPC1 mutations, along with other clinical findings, such as positive deep tendon reflexes and normal peripheral nerve conduction velocity testing, which could help in considering other diseases as differential diagnoses.
肌球蛋白结合蛋白 C1(MYBPC1)编码肌球蛋白结合蛋白 C,慢型(sMyBP-C),一种调节肌球蛋白交联的辅助蛋白,稳定粗丝,并调节肌节中的收缩性,最近与震颤性肌病有关。在儿童早期表现出的 MYBPC1 突变的临床特征与脊髓性肌萎缩症(SMA)有些相似,例如低张力、舌和四肢的不自主运动以及运动发育迟缓。新型 SMA 治疗方法的发展使得在婴儿早期区分 SMA 与其他疾病变得非常重要。我们报告了 MYBPC1 突变的特征性舌运动,以及其他临床发现,例如阳性深腱反射和正常的周围神经传导速度测试,这有助于考虑其他疾病作为鉴别诊断。